Biomedical Technologies for In Vitro Screening and Controlled Delivery of Neuroactive Compounds

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 3, 2008-01 ,pp. : 203-219

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2147-2157

Bentham Science Publishers

Access to resources Recommend Favorite

Research on heterocyclic compounds. Part XXXVI. Imidazo[1,2-a]pyrimidine-2-acetic derivatives: synthesis and antiinflammatory activity

By Saachi A.   Laneri S.   Arena F.   Luraschi E.   Abignente E.   D'Amico M.   Berrino L.   Rossi F.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 7, 1997-07 ,pp. : 677-682

Elsevier

Access to resources Recommend Favorite

Research on heterocyclic compounds, XLI. 2-Phenylimidazo[1,2-b]pyridazine-3-acetic derivatives: synthesis and anti-inflammatory activity

By Sacchi A.   Laneri S.   Arena F.   Abignente E.   Gallitelli M.   D'amico M.   Filippelli W.   Rossi F.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 1003-1008

Elsevier

Access to resources Recommend Favorite

Research on heterocyclic compounds - Part XXXIX. 2-Methylimidazo[1,2-a]pyrimidine-3-carboxylic derivatives: Synthesis and antiinflammatory activity

By Laneri S.   Sacchi A.   Gallitelli M.   Arena F.   Luraschi E.   Abignente E.   Filippelli W.   Rossi F.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 3, 1998-03 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite